triple hormone receptor agonist retatrutide Medscape | Retatrutide, Eli Lilly's first-in-class agonist, delivered meaningful weight loss at 80 weeks in all doses in the Retatrutide: A Triple Agonist Shaping

Evidence-Based Complementary and Alternative Medicine: ECAM, 2012

The newest research shows that these medications may have a neuroprotective effect, which means that GLP-1 medications may shield nerves cells from damage and inflammation

doi: 10.1172/JCI57256 [DOI] [PMC free article] [PubMed] [Google Scholar] 225

Henry Berler 25 captures the contradiction at the heart of this trend: Now, teenagers are being taught acceptance, but reality is not lining up with that because our role models, whether that be our parents or celebrities, are able to buy perfection rather than loving or accepting how they already are

Allow the medication to reach room temperature if it has been refrigerated (typically 1530 minutes), as cold injections can be more uncomfortable

It is also not clear if the GFR threshold is all that matters since MALA usually occurs in the setting of heart failure, sepsis, shock, or AKI (which can occur at any GFR)